Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 93-98, February 2010

Prognosis of Stage A or B Heart Failure Patients With Elevated B-type Natriuretic Peptide Levels

  • Lori B. Daniels, MD, MAS

      Affiliations

    • Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA
    • Corresponding Author InformationReprint requests: Lori B. Daniels, MD, MAS, Mail Code 0986, 9350 Campus Point Dr., Suite 1D, La Jolla, CA 92037-1300. Tel: (858) 775-9214; Fax: (858) 657-8021.
    • ,
  • Paul Clopton, MS

      Affiliations

    • Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA
    • Veteran's Affairs San Diego Healthcare System, La Jolla, CA
    • ,
  • Kevin Jiang, BS

      Affiliations

    • Veteran's Affairs San Diego Healthcare System, La Jolla, CA
    • ,
  • Barry Greenberg, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA
    • ,
  • Alan S. Maisel, MD

      Affiliations

    • Division of Cardiology, Department of Medicine, University of California at San Diego, San Diego, CA
    • Veteran's Affairs San Diego Healthcare System, La Jolla, CA

Received 21 April 2009; received in revised form 26 September 2009; accepted 8 October 2009. published online 16 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by a grant from the American College of Cardiology/Guidant Foundation, Bethesda, MD (L.B.D.). Abbott Inc. supplied the reagents for analyzing the biomarkers for this report, but had no input into data acquisition, data analysis, manuscript preparation, or any other aspect of the study. A.S.M. has received research grants from Abbott, Roche, and Bayer, and is a consultant for Biosite. L.B.D. has received research support from Roche and Biosite; there are no other conflicts of interest to report.

PII: S1071-9164(09)01130-0

doi:10.1016/j.cardfail.2009.10.020

Journal of Cardiac Failure
Volume 16, Issue 2 , Pages 93-98, February 2010

Article Tools

* Image Usage & Resolution